These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8232785)

  • 1. Intravenous immune globulin is also an efficient therapy of acute Guillain-Barré syndrome in affected children.
    Vallée L; Dulac O; Nuyts JP; Leclerc F; Vamecq J
    Neuropediatrics; 1993 Aug; 24(4):235-6. PubMed ID: 8232785
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefit of intravenously administered immune serum globulin in patients with Guillain-Barré syndrome.
    Shahar E; Murphy EG; Roifman CM
    J Pediatr; 1990 Jan; 116(1):141-4. PubMed ID: 2295955
    [No Abstract]   [Full Text] [Related]  

  • 3. Relapse in Guillain-Barré syndrome after treatment with human immune globulin.
    Irani DN; Cornblath DR; Chaudhry V; Borel C; Hanley DF
    Neurology; 1993 May; 43(5):872-5. PubMed ID: 8492939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulins in the treatment of Guillain-Barré syndrome in early childhood.
    al-Qudah AA
    J Child Neurol; 1994 Apr; 9(2):178-80. PubMed ID: 8006371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single high-dose intravenous immunoglobulin for treatment of pediatric Guillain-Barré syndrome.
    Wong BL; Glauser TA
    J Child Neurol; 1998 Mar; 13(3):146. PubMed ID: 9535240
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome.
    Rajah A
    Anaesthesia; 1992 Mar; 47(3):220-2. PubMed ID: 1566990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune globulins are effective in severe pediatric Guillain-Barré syndrome.
    Shahar E; Shorer Z; Roifman CM; Levi Y; Brand N; Ravid S; Murphy EG
    Pediatr Neurol; 1997 Jan; 16(1):32-6. PubMed ID: 9044398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome.
    Hughes RA; Rees JH
    Curr Opin Neurol; 1994 Oct; 7(5):386-92. PubMed ID: 7804457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome in a 93-year-old woman: rapid improvement of neurologic function following intravenous immunoglobulin.
    Uldry PA; Bogousslavsky J; Regli F
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(4):301-5. PubMed ID: 1719624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of acute polyradiculoneuritis (Guillain-Barré syndrome)].
    Hartung HP; Gold R; Zielasek J; Archelos JJ; Toyka KV
    Nervenarzt; 1994 Dec; 65(12):807-18. PubMed ID: 7854501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of intravenous immunoglobulins in Guillain-Barré syndrome].
    Forrett-Kaminsky MC; Scherer C; Bemer M; Robert V; Steinbach G; Poussel JF
    Presse Med; 1991 Oct; 20(31):1516. PubMed ID: 1835056
    [No Abstract]   [Full Text] [Related]  

  • 12. Human immune globulin infusion in Guillain-Barré syndrome: worsening during and after treatment.
    Castro LH; Ropper AH
    Neurology; 1993 May; 43(5):1034-6. PubMed ID: 8492921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome.
    Raphael JC; Chastang C; Chevret S; Gajdos P
    N Engl J Med; 1992 Sep; 327(11):816; author reply 817. PubMed ID: 1501669
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of acute Guillain-Barré syndrome. A national multicenter study].
    Kloss TM; Haupt WF; Philipp T; Diener HC
    Nervenarzt; 1994 Dec; 65(12):881-3. PubMed ID: 7854512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases].
    Uldry PA; Bogousslavsky J; Regli F
    Rev Neurol (Paris); 1991; 147(8-9):573-6. PubMed ID: 1962066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin as therapy for pediatric Guillain-Barré syndrome.
    Abd-Allah SA; Jansen PW; Ashwal S; Perkin RM
    J Child Neurol; 1997 Sep; 12(6):376-80. PubMed ID: 9309521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Guillain-Barré syndrome.
    Van der Meché FG
    Baillieres Clin Neurol; 1994 Apr; 3(1):73-94. PubMed ID: 7921592
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome.
    Huh M; Davis W
    N Engl J Med; 1992 Sep; 327(11):817. PubMed ID: 1501670
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune globulin therapy in children with Guillain-Barré syndrome.
    Goodhew PM; Johnston HM
    Muscle Nerve; 1996 Nov; 19(11):1490-2. PubMed ID: 8874410
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe Guillain-Barré syndrome in childhood treated with human immune globulin.
    Reisin RC; Pociecha J; Rodriguez E; Massaro ME; Arroyo HA; Fejerman N
    Pediatr Neurol; 1996 May; 14(4):308-12. PubMed ID: 8805174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.